Variation in US private health plans&apos; coverage of orphan drugs.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To compare coverage of orphan and nonorphan drugs, to examine variation in orphan drug coverage across the largest US private plans, and to evaluate factors influencing coverage decisions.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am J Manag Care

Title: The American journal of managed care

Publisher:

ISSN (Electronic): 1936-2692

ISSN (Print): 1088-0224

Publication date (Electronic): October 2019

Volume: 25

Issue: 10

Affiliations

[1 ] Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St #63, Boston, MA 02111. Email: jchambers@tuftsmedicalcenter.org.

Article

Publisher Item ID: 88158

PubMed ID: 31622066

SO-VID: a107a318-bd06-4e6f-8ecb-df223165f872

History

Data availability:

Comments

Comment on this article

Cited by 10

See all cited by

Variation in US private health plans' coverage of orphan drugs.

Read this article at